Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

PR NewswireMay 2 19:30

Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

PR NewswireApr 25 05:05

Carisma Therapeutics, Inc. (NASDAQ:CARM) Not Doing Enough For Some Investors As Its Shares Slump 33%

Carisma Therapeutics, Inc. (NASDAQ:CARM) shareholders won't be pleased to see that the share price has had a very rough month, dropping 33% and undoing the prior period's positive performance. The

Simply Wall StApr 24 18:20

Buy Rating on Carisma Therapeutics: Pioneering CAR-M Therapies in Oncology and Fibrosis

TipRanksApr 24 02:25

Analysts Are Bullish on These Healthcare Stocks: Neurocrine (NBIX), Carisma Therapeutics (CARM)

TipRanksApr 24 02:20

Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Preclinical data highlights the potential of engineered macrophage cell therapy as a treatment for liver and lung fibrosis Novel Redirected Soluble Modulator technology has demonstrated the potentia

PR NewswireApr 23 04:35